| 2024/05/02 18:18:34 | |
|---|---|
| Price | |
| 133.45 USD | |
| Difference | 1.95% (2.55) |
General attributes
| ISIN | US8036071004 |
| Symbol | SRPT |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,543 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 133.24 USD (400) |
| Ask (Ask size) | 133.66 USD (400) |
| Open | 140.00 USD |
| High | 142.79 USD |
| Low | 132.50 USD |
| Close (prev. day) | 130.90 USD |
| VWAP | 136.771435 USD |
| Volume (pcs) | 1,247,778 |
| Trading volume | 170,756,876.79 |
| Number of trades | 14,850 |
| Last size | 100 |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/02 18:18:34 | |
|---|---|
| Price | |
| 133.45 USD | |
| Difference | 1.95% (2.55) |
General attributes
| ISIN | US8036071004 |
| Symbol | SRPT |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,543 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 133.24 USD (400) |
| Ask (Ask size) | 133.66 USD (400) |
| Open | 140.00 USD |
| High | 142.79 USD |
| Low | 132.50 USD |
| Close (prev. day) | 130.90 USD |
| VWAP | 136.771435 USD |
| Volume (pcs) | 1,247,778 |
| Trading volume | 170,756,876.79 |
| Number of trades | 14,850 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +71.07% | +4.63% | +84.78% |
| Perf (abs.) | +54.38 | +5.79 | +60.06 |
| Beta | 0.82 | 0.60 | 0.86 |
| Volatility | 40.82 | 63.05 | 54.15 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 128.50 USD (1,249,561) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 124.74 USD (741,201) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 118.02 USD (1,033,487) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 114.49 USD (1,255,481) |
| YTD High | date | 143.00 USD (2024/02/16) |
| YTD Low | date | 91.34 USD (2024/01/05) |
| 52 Weeks High | date | 159.89 USD (2023/05/15) |
| 52 Weeks Low | date | 55.25 USD (2023/10/31) |
All listings for SAREPTA THERAPEUTICS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/02 | 16:14 | 126.30 EUR | 0.02 | 4 |
| Stuttgart | 2024/05/02 | 17:48 | 125.20 EUR | 0.00 | 3 |
| Nasdaq | 2024/05/02 | 18:18 | 133.45 USD | 170.76 | 14,850 |
| Munich | 2024/05/02 | 08:00 | 129.00 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/12/01 | 16:18 | 79.5805 USD | 0.05 | 3 |
| Frankfurt | 2024/05/02 | 08:53 | 128.10 EUR | 0.00 | 1 |
| Duesseldorf | 2024/05/02 | 16:31 | 127.35 EUR | 0.00 | 4 |
| Berlin | 2024/05/02 | 08:08 | 128.20 EUR | 0.00 | 1 |
Company Profile
| - |
Members of Management Board
| M. Wilsey | Chairman of Board of Directors |
| Claude Nicaise | Member of Board of Directors |
| Hans Lennart Rudolf Wigzell | Member of Board of Directors |
| Kathryn Boor | Member of Board of Directors |
| Stephen Mayo | Member of Board of Directors |
| Michael Chambers | Member of Board of Directors |
| Richard Barry | Member of Board of Directors |